Keywords: CTX; osteopenia; osteoporosis; P1NP; T-score; Z-score;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: SSRIs; Fluoxetine; Escitalopram; P1NP; β-CTX; pCREB;
Keywords: ACa; Albumin-adjusted calcium; ANOVA; Analysis of variance; AUC; Area under the curve; BASE; Baseline; BMD; Bone mineral density; BMI; Body mass index; CON; Controlled energy availability trial; β-CTX; β-carboxyl-terminal cross-linked telopeptide of typ
Keywords: LCR; low-capacity runners; OVX; ovariectomy; SHM; Sham; SOY; Soy-protein-based diet; CON; control diet; Tb.Sp; trabecular separation; Tb.Th; trabecular thickness; Tb.N; trabecular number; Conn.D; connectivity density; Tmax; maximal torque; Ks; torsional s
Keywords: BTMs; Bone turnover markers; CTX; C-terminal cross-linked telopeptide of type I collagen; P1NP; N-terminal propeptide of type I procollagen; FGF-23; Fibroblast growth factor-23; PTH; Parathyroid hormone; BMD; bone mineral density; vBMD; Volumetric bone mi
Keywords: BMI; body mass index; CTX; C-terminal telopeptide of type I collagen; IL; interleukin; LCH; Langerhans cell histiocytosis; PINP; procollagen type I N-terminal propeptide; PTH; parathyroid hormone; Langerhans cell histiocytosis (LCH); Disease activity; P1N
Keywords: BMD; bone mineral density; BSAP; bone-specific alkaline phosphatase; CI; confidence interval; CTX; C-telopeptide of type 1 collagen; DXA; dual-energy x-ray absorptiometry; LS mean; least squares mean; P1NP; procollagen type 1Â N-terminal propeptide; Q1; f
Keywords: BMD; bone mineral density; ASD; autism spectrum disorder; HRpQCT; high resolution peripheral quantitative computer tomography; DEXA; dual-energy X-ray absorptiometry; IGF-1; insulin-like growth factor-1; TSH; thyroid stimulating hormone; T4; thyroxine; P1
Keywords: ACa; albumin-adjusted calcium; ANOVA; analysis of variance; AUC; area under the curve; BASE; baseline; BMD; bone mineral density; BMI; body mass index; BT ratio; bone turnover ratio; BTMs; bone turnover markers; CON; controlled; β-CTX; β-carboxyl-termin
Keywords: ADA; anti-drug antibody; ALN; alendronate; AUC; area under curve; BFR/BS; bone formation rate per bone surface; BMD; bone mineral density; bSEM; backscattered scanning electron microscopy; CKD-MBD; chronic kidney disease-mineral and bone disorder; CTX; ca
Keywords: Systematic Review; Extraintestinal Manifestations; Inflammatory Bowel Disease; ASAS; assessment of the ankylosing spondylitis scale; CD; Crohn's disease; CTx; c-telopeptide of type 1 collagen; ECCO; European Crohn's and Colitis Organisation; EIM; extr
Keywords: BMD; bone mineral density; BTM; bone turnover marker; CART; combined aerobic and resistance training; CTX; C-terminal telopeptides; DXA; dual-energy X-ray absorptiometry; FFQ; food frequency questionnaire; IMPAACT; improving physical activity after cancer
Keywords: 25 OHD; 25 hydroxy vitamin D; BMD; bone mineral density; BAP; bone specific alkaline phosphatase; BTM; bone turnover marker; PICP; carboxy-terminal propeptide of type I procollagen; CICP; collagen type 1C propeptide; CTX; C-terminal cross-link of collagen
Keywords: BMD; bone mineral density; CTX; C-terminal cross-linked telopeptide of type-I collagen; FGF-23; fibroblast growth factor-23; OC; osteocalcin; OPG; osteoprotegerin; P1NP; procollagen type 1 amino terminal propeptide; RANKL; Receptor Activator of Nuclear fa
Keywords: BMC; Bone mineral content; CTX; C-terminal cross-linked telopeptide; CV; Coefficient of variation; DXA; Dual-energy X-ray absorptiometry; ELISA; Enzyme-linked immunoassay; FGF23; Fibroblast growth factor 23; OCN; Osteocalcin; P1NP; N-terminal pro-peptide;
Keywords: CHO; carbohydrate; CON; control; OC; osteocalcin; CTX; carboxy-terminal of telopeptide type I collagen; P1NP; procollagen type 1N propeptide; ALP; bone alkaline phosphatase; PTH; parathyroid hormone; HPA; hypothalamic-pituitary-adrenal; DXA; dual ener
Keywords: BTM, bone turnover markers; NTX, N-telopeptide; P1NP, procollagen type 1 n-terminal propeptide; ET, estrogen therapy; SOF, Study of Osteoporotic FracturesKyphosis; Hyperkyphosis; Bone turnover; Bone remodeling; P1NP; NTX
Naringin protects against bone loss in steroid-treated inflammatory bowel disease in a rat model
Keywords: Inflammatory bowel diseases; Osteoporosis; Naringin; Glucocorticoid; Bone formation; Oxidative stress; IBD; inflammatory bowel disease; IL; interleukin; TNF; tumor necrotic factor; DEX; Dexamethasone; P1NP; procollagen type 1â¯N-terminal propeptide; DSS;
The relationship between bone turnover and insulin sensitivity and secretion: Cross-sectional and prospective data from the RISC cohort study
Keywords: P1NP; CTX; Insulin; Sensitivity; Secretion;
Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists
Keywords: BMD; bone mineral density; Col1a1; collagen, type I, alpha 1; Dkk; Dickkopf; DXA; dual-energy X-ray absorptiometry; Eif3f; eukaryotic translation initiation factor 3, subunit F; FRZB; Frizzled related protein; LRP; low density lipoprotein receptor-related
The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats
Keywords: AEDs; antiepileptic drugs; CBZ; carbamazepine; SVP; sodium valproate; LTM; levetiracetam; RANKL; receptor activator of nuclear factor kappa β-ligand; P1NP; procollagen type 1 amino-terminal propeptide; BMD; bone mineral density; DKK-1; Dickkopf 1; CPCSEA
Bone disease in β thalassemia patients: past, present and future perspectives
Keywords: AL; aledronate; BMD; bone mineral density; bw; body weight; BMD-L; lumbar spine bone mineral density; Ca; calcium supplementation; CLO; clodronate; COLIA1; collagen type I A1; D; vitamin D; DEXA; dual energy X-ray absorptiometry; DFO; desferrioxamine; DFP
Natural and synthetic polymers/bioceramics/bioactive compounds-mediated cell signalling in bone tissue engineering
Keywords: ALP; alkaline phosphatase; ANG; angiogenin; AuNPs; gold nanoparticles; BMP; bone morphogenetic protein; BSP; bone sialoprotein; BTE; bone tissue engineering; COL1; collagen type 1; CSL; CBF1/Su(H)/Lag-1 protein; ERK; extracellular signal-regulated kinase;
Osteogenesis imperfecta - A clinical update
Keywords: OI; osteogenesis imperfecta; COL1A1; a1 chain of type 1 collagen; COL1A2; a2 chain of type 1 collagen; CNS; central nervous system; aBMD; areal bone mineral density; LS; lumbar spine; BPs; bisphosphonates; RANKL; receptor activator of the nuclear factor k
Combination of PTH (1-34) with anti-IL17 prevents bone loss by inhibiting IL-17/N-cadherin mediated disruption of PTHR1/LRP-6 interaction
Keywords: PTH; parathyroid hormone; RANKL; receptor activated nuclear factor kappa B ligand; TNF-α; tumor necrosis factor; CTX-1; C-terminal telopeptide; P1NP; pro-collagen type-1 N terminal propeptide; PTH; Osteoporosis; Osteoimmunology; IL-17A;
Vitamin K and osteoporosis: Myth or reality?
Keywords: VK; Vitamin K; OC; Osteocalcin; RCTs; Randomized Control Trials; BMD; Bone Mineral Density; BTM; Bone Turnover Markers; VD; Vitamin D; Gla; γ-carboxyglutamic acid; PT; Prothrombin Time; MGP; Matrix Gla Protein; Gas-6; Growth arrest-specific 6 protein; uc
Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women
Keywords: TGF-β1; transforming growth factor β 1; SOST; sclerostin; L1-4; BMD of lumbar spine 1-4; FN; BMD of femur neck; Total hip; BMD of total hip; P1NP; N-terminal propeptide of type I collagen; PTH; parathyroid hormone; VitD; serum 25(OH)D; CTX; cross-link
Effect of vitamin D3-supplementation on bone markers (serum P1NP and CTX): A randomized, double blinded, placebo controlled trial among healthy immigrants living in Norway
Keywords: Bone markers; RCT; Vitamin D supplementation; Immigrants; 25(OH)D; CTX; P1NP
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients
Keywords: sCa; serum calcium; iP; serum phosphate; HDF; hemodiafiltration; HD; hemodialysis; BUN; blood urea nitrogen; iPTH; intact parathyroid hormone; FGF23; fibroblast growth factor 23; βMG; beta2-microglobulin; OC; osteocalcin; P1NP; aminoterminal propeptide o
A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat
Keywords: AIN; American Institute of Nutrition; Alp; alkaline phosphatase; BAP; bone-specific alkaline phosphatase; BFR; bone formation rate; BMD; bone mineral density; BMP; bone morphogenetic protein; BV/TV; bone volume per total volume; Conn Density; connectivity
Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover
Keywords: GCCT; glucocorticoid therapy; GCC; glucocorticoid; Dkk-1; Dickkopf; BMD; bone mineral density; SD; standard deviation of the mean; BMI; body mass index; bone ALP; bone alkaline phosphatase; OC; osteocalcin; P1NP; propeptide amino-terminal of type I procol
Renal function and bone mineral density in community-dwelling elderly Japanese men: The Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study
Keywords: BMD; bone mineral density; BMI; body mass index; Cr; creatinine; CTX; cross-linked carboxy-terminal telopeptide of type I collagen; CV; coefficient of variation; DXA; dual X-ray absorptiometry; eCCr; estimated creatinine clearance; eGFR; estimated glomeru
Original Full Length ArticleEvaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH2] in postmenopausal women with osteoporosis
Keywords: PTH; parathyroid hormone; rhPTH(1-31)NH2; recombinant human PTH 1-31; rhPTH(1-31)NH2; recombinant human PTH(1-31)amide; BMD; bone mineral density; PK; pharmacokinetic; DXA; Dual energy X-ray absorptiometry; P1NP; Propeptide of type I collagen; CTx
Hormonal and biochemical parameters correlated with bone densitometric markers in prepubertal Hungarian children
Keywords: 25(OH)D3; 25-hydroxy vitamin D3; tALP; total alkaline phosphatase; BMCs; bone mineral contents; BMD; bone mineral density; BMDs; bone mineral densities; BMI; body mass index; Ca; calcium; Ca-Alb; corrected Ca with albumin; CTXs; serum beta crosslaps; DXA;
Growth factor gene expression profiles of bone morphogenetic protein-2-treated human adipose stem cells seeded on calcium phosphate scaffolds in vitro
Keywords: Adipose stem cells; Trophic factors; Secretome; BMP-2; Osteogenic differentiation; Calcium phosphate; (h)ASC; (human) adipose stem cell; BCP; biphasic calcium phosphate; BMP-2; bone morphogenetic protein-2; GAPDH; glyceraldehyde 3-phosphate dehydrogenase;
Age-related reference intervals for bone turnover markers from an Australian reference population
Keywords: Bone turnover marker; P1NP; CTx; Reference interval
Effects of Bisphosphonate Treatment on Circulating Osteogenic Endothelial Progenitor Cells in Postmenopausal Women
Keywords: AP; alkaline phosphatase; CTx; carboxyterminal telopeptide of type 1 collagen; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; EPC; endothelial progenitor cell; hs-CRP; high-sensitivity C-reactive protein; IL; interleukin; IQR; int
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate
Keywords: ZOL; Zoledronic Acid; RIS; Risedronate; BMD; Bone Mineral Density; LS; Lumbar Spine; TH; Total Hip; FN; Femoral Neck; GIO; Glucocorticoid-induced Osteoporosis; HORIZON; Health Outcomes and Reduced Incidence with zoledronic Acid ONce yearly; P1NP; Procolla
Influence of age and gender on associations of body mass index with bone mineral density, bone turnover markers and circulating calcium-regulating and bone-active sex hormones
Keywords: BMD; Bone Mineral Density; BMI; Body Mass Index; β-CTx; Beta-CrossLaps; FSH; Follicle Stimulating Hormone; OPG; Osteoprotegerin; PTH; Parathyroid Hormone; P1NP; N-terminal Procollagen of type I collagen; RANKL; Receptor Activator of Nuclear Factor kappa-
Improvement in Biomarkers of Bone Formation During Infliximab Therapy in Pediatric Crohn's Disease: Results of the REACH Study
Keywords: BMI; body mass index; BSAP; bone specific alkaline phosphatase; CTX-1; C-telopeptide cross-links of type I collagen; DPD; deoxypyridinoline; ELISA; enzyme-linked immunosorbent assay; IL; interleukin; OPG; osteoprotegerin; PCDAI; Pediatric Crohn's Disease